IMPLICATION OF A KNOWN GENE NAMED CP2/LSF-LBP-1 IN ALZHEIMER'S DESEASE

摘要

This invention concerns a method of predicting an increased risk of a human subject of developing Alzheimer's disease comprising assaying for a mutation within the ADN sequence of the CP2/LSF/LBP-1 gene including the region controlling the expression of said gene.